Qingzhi Shi
Nanchang University(CN)Second Affiliated Hospital of Nanchang University(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Blood groups and transfusion, Chronic Lymphocytic Leukemia Research, Heparin-Induced Thrombocytopenia and Thrombosis, Mesenchymal stem cell research
Most-Cited Works
- → Metformin and cancer: An existing drug for cancer prevention and therapy (Review)(2017)148 cited
- → A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia(2021)71 cited
- → Ibrutinib in CLL/SLL: From bench to bedside (Review)(2019)20 cited
- → N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest(2007)15 cited
- → Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial(2023)15 cited
- → Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study(2021)13 cited